These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
864 related items for PubMed ID: 8707337
1. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts. Qian S, Fu F, Li Y, Lu L, Rao AS, Starzl TE, Thomson AW, Fung JJ. Immunology; 1996 May; 88(1):124-9. PubMed ID: 8707337 [Abstract] [Full Text] [Related]
2. Presensitization by skin grafting from major histocompatibility complex class I or major histocompatibility complex class II deficient mice identifies class I antigens as inducers of allosensitization. Qian S, Fu F, Li Y, Gao L, Lu L, Noyola H, Rao AS, Thomson AW, Fung JJ. Immunology; 1995 May; 85(1):82-7. PubMed ID: 7635525 [Abstract] [Full Text] [Related]
3. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms. Fu F, Li W, Lu L, Thomson AW, Fung JJ, Qian S. Transplantation; 1999 Feb 15; 67(3):444-50. PubMed ID: 10030293 [Abstract] [Full Text] [Related]
4. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb. Lu L, Li W, Zhong C, Qian S, Fung JJ, Thomson AW, Starzl TE. Transplantation; 1999 Sep 27; 68(6):747-57. PubMed ID: 10515374 [Abstract] [Full Text] [Related]
5. Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients. Li W, Fu F, Lu L, Narula SK, Fung JJ, Thomson AW, Qian S. Transplantation; 1998 Dec 27; 66(12):1587-96. PubMed ID: 9884244 [Abstract] [Full Text] [Related]
16. Survival of MHC-deficient mouse heterotopic cardiac allografts. Campos L, Naji A, Deli BC, Kern JH, Kim JI, Barker CF, Markmann JF. Transplantation; 1995 Jan 27; 59(2):187-91. PubMed ID: 7839439 [Abstract] [Full Text] [Related]
17. Impact of Flt-3 ligand on donor-derived antigen presenting cells and alloimmune reactivity in heart graft recipients given adjuvant donor bone marrow. Khanna A, Antonysamy MA, Subbotin VM, Steptoe RJ, Li W, Rudert WA, Thomson AW. Transpl Immunol; 1998 Dec 27; 6(4):225-34. PubMed ID: 10342736 [Abstract] [Full Text] [Related]
18. Prolonged survival of class II transactivator-deficient cardiac allografts. June Brickey W, Felix NJ, Griffiths R, Zhang J, Wang B, Piskurich JF, Itoh-Lindstrom Y, Coffman TM, Ting JP. Transplantation; 2002 Nov 15; 74(9):1341-8. PubMed ID: 12451276 [Abstract] [Full Text] [Related]
19. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients. Ruiz P, Fuller J, Sanfilippo F. Transplantation; 1990 Jan 15; 49(1):175-83. PubMed ID: 2301009 [Abstract] [Full Text] [Related]